O Shaughnessy Asset Management LLC grew its position in shares of Henry Schein, Inc. (NASDAQ:HSIC – Get Rating) by 19.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,817 shares of the company’s stock after buying an additional 1,466 shares during the quarter. O Shaughnessy Asset Management LLC’s holdings in Henry Schein were worth $704,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors also recently modified their holdings of HSIC. Fiduciary Management Inc. WI increased its stake in shares of Henry Schein by 45.5% during the 3rd quarter. Fiduciary Management Inc. WI now owns 1,913,031 shares of the company’s stock worth $125,820,000 after purchasing an additional 597,877 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of Henry Schein by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 15,331,533 shares of the company’s stock worth $1,336,756,000 after purchasing an additional 214,846 shares during the last quarter. Macquarie Group Ltd. increased its stake in shares of Henry Schein by 7.9% during the 3rd quarter. Macquarie Group Ltd. now owns 2,434,865 shares of the company’s stock worth $159,915,000 after purchasing an additional 178,783 shares during the last quarter. Intech Investment Management LLC increased its stake in shares of Henry Schein by 210.8% during the 3rd quarter. Intech Investment Management LLC now owns 208,604 shares of the company’s stock worth $13,720,000 after purchasing an additional 141,488 shares during the last quarter. Finally, Pacer Advisors Inc. increased its stake in shares of Henry Schein by 1,487.2% during the 4th quarter. Pacer Advisors Inc. now owns 132,344 shares of the company’s stock worth $10,570,000 after purchasing an additional 124,006 shares during the last quarter. Hedge funds and other institutional investors own 95.45% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on HSIC. Barrington Research decreased their price target on shares of Henry Schein from $92.00 to $90.00 in a research note on Wednesday, May 10th. Credit Suisse Group lowered their target price on shares of Henry Schein from $99.00 to $97.00 and set an “outperform” rating on the stock in a report on Tuesday, February 28th. Piper Sandler boosted their target price on shares of Henry Schein from $85.00 to $97.00 and gave the company an “overweight” rating in a report on Monday, February 6th. Morgan Stanley lowered their target price on shares of Henry Schein from $70.00 to $69.00 and set an “underweight” rating on the stock in a report on Tuesday, February 21st. Finally, UBS Group boosted their target price on shares of Henry Schein from $75.00 to $82.00 and gave the company a “neutral” rating in a report on Tuesday, March 7th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $85.67.
Henry Schein Stock Down 0.2 %
Henry Schein (NASDAQ:HSIC – Get Rating) last announced its earnings results on Tuesday, May 9th. The company reported $1.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.02). Henry Schein had a return on equity of 15.41% and a net margin of 3.82%. The company had revenue of $3.06 billion during the quarter, compared to analysts’ expectations of $3.09 billion. During the same quarter last year, the firm posted $1.30 earnings per share. The firm’s revenue was down 3.7% on a year-over-year basis. As a group, research analysts anticipate that Henry Schein, Inc. will post 5.26 EPS for the current fiscal year.
Insider Buying and Selling at Henry Schein
In other Henry Schein news, Director Philip A. Laskawy sold 6,405 shares of the company’s stock in a transaction dated Friday, March 3rd. The shares were sold at an average price of $78.74, for a total transaction of $504,329.70. Following the completion of the sale, the director now directly owns 26,239 shares in the company, valued at $2,066,058.86. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In other news, Director Kurt P. Kuehn sold 1,909 shares of the company’s stock in a transaction dated Thursday, March 16th. The shares were sold at an average price of $77.46, for a total transaction of $147,871.14. Following the completion of the transaction, the director now directly owns 15,675 shares of the company’s stock, valued at $1,214,185.50. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Philip A. Laskawy sold 6,405 shares of the company’s stock in a transaction dated Friday, March 3rd. The shares were sold at an average price of $78.74, for a total transaction of $504,329.70. Following the transaction, the director now directly owns 26,239 shares of the company’s stock, valued at $2,066,058.86. The disclosure for this sale can be found here. Insiders sold a total of 47,942 shares of company stock worth $3,667,662 over the last three months. Company insiders own 1.14% of the company’s stock.
About Henry Schein
Henry Schein, Inc engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins.
Featured Articles
- Get a free copy of the StockNews.com research report on Henry Schein (HSIC)
- MarketBeat Week in Review – 5/22 – 5/26
- Big Lots Becomes A Stomach Churning Value Play
- The Melt-Up In Marvell Is On; But Don’t Chase It Higher
- Is Apple a Growth Stock or a Value Stock?
- Costco’s Earnings Call Reassure Economists, Recession Cancelled
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.
